International Journal of Drug Policy Volume 75 to 86

The “International Journal of Drug Policy” serves as a platform for the exchange of knowledge and discussion regarding drug use and drug policy on a global scale. Here are some key features of the journal:

1. Scope: The journal covers a broad range of topics related to drug use and drug policy, including both licit and illicit substances. It encompasses social, political, legal, and health aspects of psychoactive substance use.
2. Research and Analysis: The journal publishes current research, reviews, debates, and critical analyses on drug-related issues. It aims to provide a comprehensive understanding of the multifaceted nature of drug use and its consequences.
3. Global Perspective: “International Journal of Drug Policy” takes a global perspective, recognizing that drug-related matters vary across regions and countries. It seeks to represent a wide range of material from around the world, highlighting the international relevance of drug policies and practices.
4. Focus on Consequences: The journal places particular emphasis on exploring the effects of drug policies and practices on drug-using behavior and their health and social consequences. This focus aims to shed light on the real-world impact of drug policies.
5. Multidisciplinary Approach: Given the complexity of drug-related issues, the journal welcomes contributions from various disciplines, including sociology, political science, public health, law, and more. This multidisciplinary approach fosters a holistic understanding of drug policy and its implications.
6. Diversity of Material: The journal publishes diverse material related to drug use and policy, ensuring a wide range of perspectives and insights. It provides a platform for researchers, policymakers, and practitioners to share their work and experiences.

Overall, the “International Journal of Drug Policy” serves as a valuable resource for those interested in gaining insights into the global landscape of drug use and drug policy. It encourages dialogue and critical analysis to inform evidence-based drug policies and practices that consider the social, legal, and health contexts of drug-related issues.